We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Emergency Authorization of Diagnostics Hampered by IT, Staffing, Validation Issues, Report Says
FDA’s Emergency Authorization of Diagnostics Hampered by IT, Staffing, Validation Issues, Report Says
An analysis of the FDA’s Emergency Use Authorization (EUA) process for COVID-19 diagnostic tests found that the lack of automation in the submission and tracking system hampered product reviews by the agency.